Neil Dahiya

Ainos Inc, a pioneering healthcare firm based in San Diego that specializes in advanced AI-enhanced point-of-care diagnostics and low-dose interferon therapies, has disclosed that it has entered into a crucial memorandum of understanding (MoU) with Taiwan Tanabe Seiyaku Co, Ltd.

AlveoGene, a company dedicated to revolutionizing treatments for rare respiratory conditions through inhaled gene therapies, has announced that its novel therapy, AVG-002, has received Orphan Drug Designation from the US Food & Drug Administration (FDA). This recognition is for AVG-002’s

### **Merck’s Latest Lung Cancer Therapy Receives FDA Breakthrough Designation** Merck, operating as MSD outside the USA and Canada, revealed that the U.S. Food and Drug Administration (FDA) has awarded a Breakthrough Therapy designation to sacituzumab tirumotecan (sac-TMT) aimed at

Orbit Discovery, a leader in peptide discovery services, and Evergreen Theragnostics, a pioneer in radiopharmaceuticals and precision medicine, today announced the extension of their research collaboration to develop innovative targeting peptides for radiopharmaceutical applications. This expansion builds on a previous

We have submitted an application to renew the registration of the Ethics Committee (EC) with the relevant authorities. The EC, however, has yet to receive confirmation of renewal from these authorities. Is it permissible for the EC to proceed with

In an effort to nurture the budding medical devices sector within the nation, the central government has initiated a scheme titled ‘Enhancement of Medical Device Industry,’ earmarking an initial fund of Rs. 500 crore across three years from 2024-25 to